How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

17 results for

Pseudohypertension

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Prevalence and clinical characteristics of pseudohypertension in elderly patients prepared for coronary artery angiography. (PubMed)

Prevalence and clinical characteristics of pseudohypertension in elderly patients prepared for coronary artery angiography. Pseudohypertension (PHT) can cause adverse effects in the elderly owing to administration of antihypertension therapy. The present study aimed to determine the prevalence of PHT in the elderly and associated risk factors to investigate a noninvasive method of detection of PHT.We recruited 151 patients (age ≥60 years) who underwent coronary angiography. Demographic

Full Text available with Trip Pro

2017 Medicine

2. Pseudohypertension

Pseudohypertension Pseudohypertension Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Pseudohypertension Pseudohypertension Aka (...) : Pseudohypertension From Related Chapters II. Definition Severe arteriosclerosis interferes with accurate measurement III. Pathophysiology Arteries affected by severe arteriosclerosis do not compress normally with a cuff IV. Epidemiology Common cause of high readings in older patients V. Symptoms or weakness follows taking prescribed antihypertensives VI. Signs Radial artery pulse is palpable despite an upper arm inflated cuff occluding the brachial artery Images: Related links to external sites (from Bing

2018 FP Notebook

4. Pseudohypertension

Pseudohypertension Pseudohypertension Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Pseudohypertension Pseudohypertension Aka (...) : Pseudohypertension From Related Chapters II. Definition Severe arteriosclerosis interferes with accurate measurement III. Pathophysiology Arteries affected by severe arteriosclerosis do not compress normally with a cuff IV. Epidemiology Common cause of high readings in older patients V. Symptoms or weakness follows taking prescribed antihypertensives VI. Signs Radial artery pulse is palpable despite an upper arm inflated cuff occluding the brachial artery Images: Related links to external sites (from Bing

2015 FP Notebook

5. Pseudohypertension secondary to a noncompressible brachial artery (PubMed)

Pseudohypertension secondary to a noncompressible brachial artery The interesting problem is considered of a comatose alcoholic diabetic with an extremely high systolic blood pressure, as determined by the usual means, who was subsequently found to have severe medial calcinosis and normal intraarterial blood pressure. The syndrome of the noncompressible brachial artery surely accounts for this patient's falsely elevated blood pressure reading. Though infrequently reported, this condition can

Full Text available with Trip Pro

1974 Canadian Medical Association Journal

7. Choice of therapy for Adults With Hypertension Without Compelling Indications for Specific Agents

1992;146:1997-2005. Forette F, Rigaud AS, Morin M, Gisselbrecht M, Bert P. Assessing vascular dementia. Neth J Med 1995;47:185-94. Kuwajima I, Hoh E, Suzuki Y, Matsushita S, Kuramoto K. Pseudohypertension in the elderly. J Hypertens 1990;8:429-32. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ebkom T, Wester PO. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet 1991;338:1281-5. Coope J, Warrender TS. Randomized trial of treatment of elderly

2018 Hypertension Canada

8. Quality Control of the Foot Revascularization Using Indocyanine Green Fluorescence Imaging. (PubMed)

, an in-line flow from the aorta to the foot was not achieved due to a failure to recanalize the occlusion (n = 7) or due to distal embolization (n = 2). ABI was not reliable in 58 patients (57.4%) mostly due to pseudohypertension and TPs in 49 (48.5%) patients mostly due to previous minor amputations. ICG-FI was successful in all patients. The mean intensity values before and after the procedure in patients who underwent successful revascularization were 81 ± 47 units and 120 ± 5 units of intensity (p

Full Text available with Trip Pro

2017 World Journal of Surgery

9. A Clinical Trial to Evaluate Safety and Efficacy of a Renal Denervation System in Treatment of Hypertension

for the procedure (renal stenosis ≥50%, aneurysm, renal artery diameter <4mm or length<20mm) ; Only one kidney or kidney transplant recipient Prior renal artery interventional procedures or prior RDN treatment; Any conditions affecting accuracy of blood pressure measurement, such as diameter of upper arm too large for the cuff or severe arrhythmia; Secondary hypertension other than CKD hypertension; Pseudohypertension; History of orthostatic hypotension; Average systolic blood pressure (ASBP) <135mmHg based

2017 Clinical Trials

10. Treatment of hypertension in older persons: what is the evidence? (PubMed)

Treatment of hypertension in older persons: what is the evidence? Evidence for treatment of hypertension in older people is limited to placebo-controlled studies that reduced blood pressure in persons over 60 years who had systolic blood pressure >160 mmHg. Generally, physicians measure blood pressure poorly, failing to look for white coat or masked hypertension, orthostasis, postprandial hypotension, or pseudohypertension. There is evidence that if 24-hour ambulatory blood pressures were

2014 Drugs & Aging

13. Renal Sympathetic Denervation and Insulin Sensitivity (RENSYMPIS Study)

contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 30 Years to 69 Years (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Resistant Hypertension (systolic blood pressure >160mmHg and 3 or more antihypertensive agents in use) Age 30- 69 years Written informed consent Exclusion Criteria: Secondary hypertension Pseudohypertension

2013 Clinical Trials

14. Evaluation of Safety Mechanisms of Renal Radioablation(RSRA)for Uncontrolled Hypertension

HTN: Efficacy: Assessment of BP lowering effect in patients with true resistant HTN. In contrast to studies done so far, we will evaluate the true BP lowering effect of RSRA by performance of 24-hr ABPM prior to and at defined time points post procedure. We will screen out pseudohypertension using direct observed therapy. We will employ a rigorous protocol to include only patients with truly resistant HTN. Namely, we will screen for major forms of secondary HTN such as renal artery stenosis

2013 Clinical Trials

15. Evaluation of the Elderly Patient

, and any irregularity is noted. Because many factors can alter BP, BP is measured several times after patients have rested > 5 min. BP may be overestimated in elderly patients because their arteries are stiff. This rare condition, called pseudohypertension, should be suspected if dizziness develops after antihypertensives are begun or doses are increased to treat persistently elevated systolic BP. All elderly patients are checked for orthostatic hypotension because it is common. BP is measured

2013 Merck Manual (19th Edition)

16. Report of the Canadian Hypertension Society Consensus Conference: 4. Hypertension in the elderly. (PubMed)

Report of the Canadian Hypertension Society Consensus Conference: 4. Hypertension in the elderly. Several knowledge gaps, which made evidence-based guidelines impossible in 1985, have since been filled. There is now unequivocal evidence that treatment of isolated systolic hypertension benefits elderly patients, as does treatment beyond the age of 75 years. Pseudohypertension, although occasionally problematic, is not common and is not a reason to neglect the treatment of elderly patients

Full Text available with Trip Pro

1993 CMAJ: Canadian Medical Association Journal

17. Systolic hypertension in the elderly: controlled or uncontrolled. (PubMed)

pressure measurements in the fasting state and sitting and supine blood pressure measurements before and during therapy. Pseudohypertension, although rare, should be kept in mind. There is a clear risk associated with ISH for stroke, CVD, and premature death, which increases with age and rising levels of SBP. ISH can be controlled effectively with pharmacologic therapies. A reasonable goal is a 20 mmHg reduction in systolic pressure. Proof of reduced risk for stroke, CHD, and death in those

1990 Cardiovascular clinics Controlled trial quality: uncertain

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>